Rigel Pharmaceuticals Ownership | Who Owns Rigel Pharmaceuticals?
Rigel Pharmaceuticals Ownership Summary
Rigel Pharmaceuticals is owned by 13.80% institutional investors, 2.62% insiders, and 83.58% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 9.64% of RIGL shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 3.07% of its assets in Rigel Pharmaceuticals shares.
RIGL Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Rigel Pharmaceuticals | 13.80% | 2.62% | 83.58% |
| Sector | Healthcare Stocks | 42.50% | 10.81% | 46.69% |
| Industry | Biotech Stocks | 45.24% | 10.75% | 44.01% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock funding, inc. /de | 1.72M | 9.64% | $48.87M |
| Vanguard group | 1.04M | 5.83% | $29.55M |
| Goldman sachs group | 737.03K | 4.12% | $20.88M |
| Armistice capital | 724.00K | 4.05% | $20.51M |
| Acadian asset management | 685.72K | 3.83% | $19.41M |
| Marshall wace, llp | 601.33K | 3.36% | $17.04M |
| Capitolis liquid global markets | 591.55K | 3.31% | $16.76M |
| State street | 554.32K | 3.10% | $15.70M |
| Renaissance | 474.21K | 2.65% | $13.43M |
| Geode capital management | 423.72K | 2.37% | $12.01M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Cm management | 225.00K | 5.31% | $6.37B |
| Beacon harbor wealth advisors | 152.13K | 1.01% | $4.31M |
| Globeflex capital l p | 217.63K | 0.95% | $6.17M |
| Empire financial management company | 89.51K | 0.58% | $2.54M |
| Soleus capital management | 330.01K | 0.47% | $9.35M |
| Range financial group | 45.38K | 0.46% | $1.29M |
| Pharvision advisers | 20.52K | 0.33% | $581.39K |
| Armistice capital | 724.00K | 0.30% | $20.51M |
| Hillsdale investment management | 284.39K | 0.24% | $8.06M |
| Opaleye management | 37.79K | 0.15% | $1.07M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Goldman sachs group | 737.03K | 0.00% | 554.79K |
| Jane street group | 321.89K | 0.00% | 304.56K |
| Renaissance | 474.21K | 0.02% | 237.76K |
| Marshall wace, llp | 601.33K | 0.02% | 232.38K |
| Qube research | 360.97K | 0.01% | 189.54K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | - | - | -14.80M |
| Nuveen asset management | - | - | -3.22M |
| Jacobs levy equity management | - | - | -2.29M |
| Morgan stanley | 146.27K | 0.00% | -1.37M |
| Healthcare of ontario pension plan trust fund | - | - | -1.36M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Beacon harbor wealth advisors | 152.13K | 1.01% | 152.13K | $4.31M |
| Schroder investment management group | 71.82K | 0.00% | 71.82K | $2.06B |
| First trust advisors lp | 57.62K | 0.00% | 57.62K | $1.63M |
| Range financial group | 45.38K | 0.46% | 45.38K | $1.29M |
| Walleye capital | 37.95K | 0.00% | 37.95K | $1.08M |
Sold Out
| Holder | Change |
|---|---|
| Ifp advisors | -1.00 |
| Synergy asset management | -15.00 |
| Strategic investment solutions, inc. /il | -25.00 |
| Harbour investments | -40.00 |
| Physician wealth advisors | -50.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 48 | -61.29% | 2,467,259 | -82.23% | 13 | 0.23% | 24 | -61.90% | 14 | -61.11% |
| Jun 30, 2025 | 123 | 0.82% | 13,882,606 | -0.14% | 77 | 1.27% | 62 | -3.13% | 36 | -5.26% |
| Mar 31, 2025 | 3 | -97.60% | 1,156,951 | -90.41% | 6 | 0.14% | 1 | -98.78% | 1 | -95.24% |
| Dec 31, 2024 | 6 | 50.00% | 1,212 | 65.35% | - | 39369.05% | 2 | 100.00% | - | - |
| Sep 30, 2024 | 4 | -55.56% | 733 | -94.24% | - | 7854.79% | 1 | -50.00% | - | -100.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard US Total Market Shares ETF | 548.78K | 3.07% | - |
| Vanguard Total Stock Mkt Idx Inv | 536.88K | 2.99% | -11.90K |
| iShares Russell 2000 ETF | 427.43K | 2.38% | - |
| SPDR® S&P Biotech ETF | 223.01K | 1.24% | 500.00 |
| Vanguard Institutional Extnd Mkt Idx Tr | 192.22K | 1.07% | -83.92K |
| Lazard US Sm Cap Eq WW Dist EUR | 176.06K | 0.98% | 27.20K |
| Fidelity Small Cap Index | 176.02K | 0.98% | -172.00 |
| Delaware Healthcare I | 160.00K | 0.91% | - |
| Macquarie Healthcare I | 160.00K | 0.89% | - |
| iShares Russell 2000 Growth ETF | 153.36K | 0.85% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Feb 04, 2025 | Schorno Dean L | EVP & Chief Financial Officer | Sell | $42.60K |
| Feb 05, 2025 | Schorno Dean L | EVP & Chief Financial Officer | Sell | $38.02K |
| Feb 05, 2025 | Santos David A | EVP, Chief Commercial Officer | Sell | $39.38K |
| Feb 04, 2025 | Santos David A | EVP, Chief Commercial Officer | Sell | $44.46K |
| Feb 04, 2025 | RODRIGUEZ RAUL R | CEO, President | Sell | $103.60K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q3 | - | - |
| 2025 Q2 | - | - |
| 2025 Q1 | - | 8 |
| 2024 Q4 | - | - |
| 2024 Q3 | - | - |
RIGL Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools